Reddy US Therapeutics

Reddy US Therapeutics (RUSTI) is the United States-based drug discovery and development subsidiary of Dr. Reddy's Laboratories. Based in Princeton, New Jersey, the company serves as a strategic R&D hub focused on the identification and early-stage development of New Chemical Entities (NCEs) and proprietary specialty products. RUSTI's research efforts primarily target high-unmet-need areas in oncology, dermatology, and inflammatory diseases. The organization plays a critical role in advancing Dr. Reddy's global innovation pipeline by leveraging local expertise and fostering collaborations within the US biotechnology ecosystem. Its portfolio includes a range of small molecules and biologics aimed at providing novel therapeutic options for chronic conditions.